6-KThe Wire
HUTCHMED (China) Ltd files 6-K
Filed Jun 12, 2026 · 21d ago · Accession 0001648257-26-000039
Plain English
This Form 6-K reports on HUTCHMED (CHINA) LIMITED's presentation of Phase III data for sovleplenib ESLIM-02 at the EHA 2026 Congress. The filing does not contain financial statements.
Filing details
- Company
- HUTCHMED (China) Ltd
- Ticker
- HCM
- CIK
- 1648257
- Form type
- 6-K
- Filing date
- Jun 12, 2026
- Report date
- Jun 12, 2026
- Document
- hcm-20260612x6k.htm
- Size
- 61 KB